Hasil Pencarian - Josep Piulats

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    343 Phase 3 study of pembrolizumab + docetaxel and prednisone/prednisolone for metastatic castration-resistant prostate cancer (mCRPC) pretreated with next-generation hormonal agents (NHAs) (KEYNOTE-921)

    343 Phase 3 study of pembrolizumab + docetaxel and prednisone/prednisolone for metastatic castration-resistant prostate cancer (mCRPC) pretreated with next-generation hormonal agen... oleh Ben Li, Neal Shore, Charles Schloss, Daniel Petrylak, Karim Fizazi, Mostefa Bennamoun, Raffaele Ratta, Josep Piulats

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp

    538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp oleh Joseph Sacco, Richard Carvajal, Omid Hamid, Marcus Butler, Jason Luke, Takami Sato, Paul Nathan, Jessica Hassel, Douglas Johnson, Leonel Hernandez-Aya, Alexander Shoushtari, Josep Piulats, Enrique Espinosa, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Michelle McCully, Shaad Abdullah

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of 22 months of follow-up

    347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of... oleh Urban Emmenegger, Howard Gurney, Emanuela Romano, Neal Shore, Margitta Retz, Christian Poehlein, Charles Schloss, Leonard Appleman, Gwenaelle Gravis, Loïc Mourey, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    351 KEYNOTE-365 cohort D: pembrolizumab plus abiraterone acetate and prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC)

    351 KEYNOTE-365 cohort D: pembrolizumab plus abiraterone acetate and prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) oleh Urban Emmenegger, Christian Poehlein, Charles Schloss, Leonard Appleman, Loïc Mourey, Anthony Joshua, Mark Linch, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li, Michael Stoeckle, Jose Arranz, Nataliya Mar

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: